6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one

6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one is an impurity of Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or other parts of the body in patients who have already been treated with at least one other chemotherapy medication. Erlotinib is in a class of medications called kinase inhibitors.

Additional information on 6 | 6' | 7 | 7'-Tetrakis(2-methoxyethoxy)-4H-[3 | 4'-biquinazolin]-4-one

Catalogue No.

VE008800

CAS No.

N/A

Molecular Formula

C28H34N4O9

Molecular Weight

570.59 g/mol

Parent drug

Erlotinib

IUPAC Name

6, 6', 7, 7'-Tetrakis(2-methoxyethoxy)-4H-[3, 4'-biquinazolin]-4-one

Synonyms

N/A

References

“Erlotinib: MedlinePlus Drug Information.” Medlineplus.gov, 2017, medlineplus.gov/druginfo/meds/a605008.html.

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one

6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one
Catalogue No.

VE008800

CAS No.

N/A

Molecular Formula

C28H34N4O9

Molecular Weight

570.59 g/mol

Parent drug

Erlotinib

IUPAC Name

6, 6', 7, 7'-Tetrakis(2-methoxyethoxy)-4H-[3, 4'-biquinazolin]-4-one

Synonyms

N/A

References

“Erlotinib: MedlinePlus Drug Information.” Medlineplus.gov, 2017, medlineplus.gov/druginfo/meds/a605008.html.

Status

In-stock

ListName

6, 6', 7, 7'-Tetrakis(2-methoxyethoxy)-4H-[3, 4'-biquinazolin]-4-one

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden